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Abstract
Background: RAW 264.7 cells can differentiate into osteoclasts when cultured in medium supplemented with 1 %
FBS. However, the proteomic changes in the development of RAW 264.7 cells into osteoclasts in low serum culture
system have not been elucidated. Therefore, we conducted quantitative proteomics analysis to investigate proteomic
changes during osteoclastogenesis in low serum culture system.
Results: Our study confirmed that mature multinucleated osteoclasts were generated in a low serum culture system,
validated by upregulated expression of 15 characteristic marker proteins, including TRAP, CTSK, MMP9, V-ATPase and
ITGAV. Proteomics results demonstrated that 549 proteins expressed differentially in osteoclastogenesis in low serum
culture system. In-depth bioinformatics analysis suggested that the differentially expressed proteins were mainly
involved in mitochondrial activities and energy metabolism, including the electron transport chain pathway, TCA
cycle pathway, mitochondrial LC-fatty acid beta-oxidation pathway and fatty acid biosynthesis pathway. The data
have been deposited to the ProteomeXchange with identifier PXD001935.
Conclusion: Osteoclast formation is an ATP consuming procedure, whether occurring in a low serum culture
system or a conventional culture system. In contrast to osteoclasts formed in conventional culture system, the
fatty acid biosynthesis pathway was upregulated in osteoclasts cultured in low serum condition.
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Background
Osteoporosis is a skeletal disorder characterized by
diminished bone mineral density and deteriorated bone
micro-structure, which consequently leads to increased
fracture risk, especially in the elder population. Epi-
demiological study revealed that more than 75 million
people suffer from osteoporosis in United States, Europe,
and Japan [1]. It is estimated that approximately 40 % of
Caucasian women and 13 % of Caucasian men aged over
50 years old will suffer from osteoporosis-related frac-
ture in the United States [2, 3]. Osteoporosis and
osteoporosis-related fractures therefore have become a
major public health concern, and impose enormous
health care costs. Burge et al. demonstrated that annual
costs for osteoporosis-related fractures were US$13.7 to
US$20.3 billion, and predicted that the costs would in-
crease to US$25.3 billion annually by 2025 in the United
States [4]. Therefore, investigating the pathological mech-
anisms of osteoporosis will be of great help to reduce the
tremendous osteoporosis related costs and promote life
quality of elder populations.
Over-activation of bone resorption plays a critical role
in the pathological mechanisms of osteoporosis [5]. To
date, large multinucleated cells termed osteoclasts are
the exclusive cells known to have the ability of bone
resorption. Thus, studying the molecular mechanisms
of osteoclast formation is essential for investigating
pathological mechanisms of osteoporosis. Osteoclasts
derive from monocyte/macrophage cells [6]. Followed
activation of the receptor activator of nuclear factor B
ligand (RANKL)/RANK signaling pathway by RANKL,
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downstream signaling cascades are stimulated, includ-
ing the IκB kinase (IKK) signaling, c-Jun N-terminal
kinase (JNK) signaling, NF-κB signaling and MAPK
signaling [7–10]. Subsequently, monocyte/macrophage
cells differentiate and fuse into mature multinucleated
osteoclasts, regulated by nuclear factor of activated T-
cells, cytoplasmic, calcineurin-dependent 1 (NFATc1) and
microphthalmia-associated transcription factor (MITF)
[11]. However, the molecular mechanisms of osteoclast
formation still need to be elucidated.
The cultivation of osteoclasts in vitro is a prerequisite
for studying the molecular mechanisms of osteoclasts.
Traditionally, a 10 % volume fraction of serum is used to
culture osteoclasts. We and other researchers previously
demonstrated that RAW264.7 cells, an osteoclast pre-
cursor cell line, could differentiate into mature bone
resorbing osteoclasts when cultured both in 1 % serum
and serum-deprived medium [12, 13]. Our previous
study revealed that a number of proteins and molecular
signaling pathways, including electron transport chain
and oxidative phosphorylation pathways, were altered in
RAW264.7 cells cultured in low serum compared to
those cultured in the conventional 10 % culture system
[13]. An et al. have performed proteomics analysis to
study the changes in global protein expression during
osteoclastogenesis in conventional culture system [14].
However, to the best of our knowledge, the proteomic
changes that occur in RAW 264.7 cells as they differen-
tiate into osteoclasts in a low serum culture system has
not been reported. In the present study, we used TMT
labeling to analyze the quantitative proteomic changes
during osteoclastogenesis in medium supplemented with
1 % FBS.
Results
Conformation of osteoclastogenesis in a low serum
culture system
To validate the formation of osteoclasts in medium sup-
plemented with 1 % FBS, we performed TRAP staining
and bone resorption assay. After 5 days cultivation,
TRAP-positive cells with more than 3 nuclei could be
observed (Fig. 1a), and the simulated bone mineral
surface was remarkably resorbed (Fig. 1b). These results
confirmed that formation of mature multinucleated oste-
oclasts could be obtained in a low serum culture system.
The tartrate-resistant acid phosphatase type 5 (TRAP or
ACP5; Accession Number: Q05117), cathepsin K (CTSK;
Accession Number: P55097), matrix metalloproteinase-9
(MMP9; Accession Number: P41245) are characteristic
osteoclast marker proteins [15]. To ensure that the large
multinucleated cells generated in our study were osteo-
clasts, quantitative proteomic data was analyzed. Our
results revealed that the three characteristic marker pro-
teins were significantly upregulated in these differenti-
ated cells. Compared to RAW 264.7 cells, TRAP, CTSK
and MMP9 in multinucleated cells were upregulated 2.59,
5.21 and 2.82-fold respectively (Table 1). The vacuolar-
type H+-ATPase (V-ATPase) proton pump complex is
typically located on the ruffled border plasma membrane
of osteoclasts [16], and can also be used as biomarker for
mature osteoclasts. Our results identified 11 subunits of
V-ATPase; all of these subunits were significantly up-
regulated (Table 1). Furthermore, bone resorbing osteo-
clasts require integrin alpha-V (ITGAV; Accession
Number: P43406) for the formation of the sealing zone
between osteoclasts and bone surface [17]. Our results
showed that the ITGAV was upregulated 2.53-fold
(Table 1). These findings clearly suggest that the giant
multinucleated cells formed in low serum culture system
were osteoclasts.
Western blot analysis of the differentially expressed
proteins
To validate the formation of osteoclasts and the results
of the quantitative LC-MS/MS data, we performed west-
ern blot analysis of three characteristic proteins of osteo-
clasts (TRAP, CTSK, MMP9) and two other differentially
expressed proteins (ANXA1, Histone H4). The expression
Fig. 1 Confirmation of osteoclast formation in low serum culture system using TRAP staining and bone resorption activity test. a TRAP-positive
multinucleated osteoclasts were successfully obtained. b Bone mineral surface was resorbed remarkably by osteoclasts generated in low serum
culture system
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of the three characteristic osteoclast proteins was sig-
nificant upregulated on western blots, confirming the
formation of osteoclasts in the low serum system. In
addition, the expression of ANXA1 and histone H4
were also upregulated, as showed in our quantitative
LC-MS/MS data. These findings indicated that our LC-
MS/MS data and subsequent analysis were confirmed
by western blotting, suggesting that the analysis results
accurately reflect changes in protein expression (Fig. 2).
Quantitative analysis of proteomic changes during
osteoclastogenesis in a low serum system
We performed quantitative proteomic analysis to com-
pare the global protein expression of RAW 264.7 cells
with those of the osteoclasts. Our results identified a
total of 6567 proteins, of which 4656 proteins with a
score of 10 or more and 2 or more unique peptides
identified were selected for further analysis. Of the 4656
proteins with high confidence, 549 proteins expressed
differentially when RAW 264.7 cells differentiated into
osteoclasts. Among the 549 differentially expressed pro-
teins, 98.5 % (541/549) were significantly upregulated,
while only 1.5 % (8/549) of proteins were downregulated
(Additional file 1: Table S1). These results indicated that
a great many proteins were upregulated, and suggested
that RAW 264.7 cells were highly activated in the de-
velopment into osteoclasts in the low serum culture
system.
Identification and classification of the differentially
expressed proteins
To understand the specific proteomic changes, we per-
formed enrichment analysis using FunRich software to
Table 1 Quantitative proteomics data of characteristic biomarkers for osteoclasts
Accession Description Score Unique peptide Tubulin adjust (128/127)
P55097 Cathepsin K OS = Mus musculus GN = Ctsk 168.11 7 5.21
P41245 Matrix metalloproteinase-9 OS =Mus musculus GN =Mmp9 58.12 15 2.82
Q05117 Tartrate-resistant acid phosphatase type 5 OS = Mus musculus GN = Acp5 104.03 10 2.59
Q9R1Q9 V-type proton ATPase subunit S1 OS =Mus musculus GN = Atp6ap1 25.62 5 2.50
Q8BVE3 V-type proton ATPase subunit H OS =Mus musculus GN = Atp6v1h 160.48 19 2.37
Q9CR51 V-type proton ATPase subunit G 1 OS = Mus musculus GN = Atp6v1g1 76.40 4 3.35
Q9D1K2 V-type proton ATPase subunit F OS =Mus musculus GN = Atp6v1f 67.21 9 2.45
P50518 V-type proton ATPase subunit E 1 OS = Mus musculus GN = Atp6v1e1 219.66 16 2.59
P57746 V-type proton ATPase subunit D OS =Mus musculus GN = Atp6v1d 130.06 12 2.33
Q80SY3 V-type proton ATPase subunit d 2 OS = Mus musculus GN = Atp6v0d2 134.85 13 3.46
P51863 V-type proton ATPase subunit d 1 OS = Mus musculus GN = Atp6v0d1 71.67 13 2.54
Q9Z1G3 V-type proton ATPase subunit C 1 OS =Mus musculus GN = Atp6v1c1 216.86 24 2.62
P62814 V-type proton ATPase subunit B, brain isoform OS =Mus musculus GN = Atp6v1b2 762.21 36 2.16
P50516 V-type proton ATPase catalytic subunit A OS =Mus musculus GN = Atp6v1a 658.00 38 2.12
P43406 Integrin alpha-V OS =Mus musculus GN = Itgav 17.86 4 2.53
Fig. 2 Validation of the LC-MS/MS data and osteoclast formation by
western blot analysis. Characteristic biomarkers of osteoclasts were
seen. TRAP, CTSK, and MMP-9 were significantly upregulated in
osteoclasts. Similar to the results from LC-MS/MS, ANXA1 and
histone H4 were upregulated in osteoclasts compared to RAW
264.7 cells
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identify and classify the differentially expressed proteins.
Of the 549 upregulated proteins, 548 proteins were
successfully mapped to the database. In the context of
cellular component, 540 of the 541 upregulated proteins
and 8 downregulated proteins matched with the data-
base. Upregulated proteins were mostly enriched in mito-
chondria, mitochondrial inner membrane, mitochondrial
matrix, extracellular exosome, myelin sheath and mito-
chondrial respiratory chain complex I (Fig. 3a). Down-
regulated proteins were enriched in the Rad6-Rad18
complex, GINS complex, replication fork protection com-
plex, clathrin coat of coated pit, microtubule plus-end and
XY body (Fig. 4a). These findings indicated that proteomic
changes mainly occurred in mitochondria when RAW
Fig. 3 Identification and classification of the upregulated proteins. a Column graph of cellular component enriched in upregulated proteins.
b Column graph of molecular function enriched in upregulated proteins. c Bar graph of biological process enriched in upregulated proteins
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264.7 cells differentiated into osteoclasts in the low serum
culture system.
According to the molecular function analysis, 482
upregulated proteins and 7 downregulated proteins
matched with the database. Our results revealed that
upregulated proteins were mainly enriched in molecular
functions of structural constituent of ribosome, NADH
dehydrogenase (ubiquinone) activity, fatty-acyl-CoA bind-
ing, 2 iron 2 sulfur cluster binding, oxidoreductase activity
and Flavin adenine dinucleotide binding (Fig. 3b). Down-
regulated proteins were enriched in cargo receptor ac-
tivity, ornithine decarboxylase activity, ubiquitin protein
Fig. 4 Identification and classification of the downregulated proteins. a Column graph of cellular component enriched in downregulated proteins.
b Column graph of molecular function enriched in downregulated proteins. c Bar graph of biological process enriched in downregulated proteins
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ligase activity, single-stranded DNA-dependent ATPase
activity, Y-form DNA binding, and clathrin adaptor activ-
ity and etc. (Fig. 4b).
In the context of biological process, upregulated pro-
teins were mainly enriched in lipid homeostasis, ATP
hydrolysis coupled proton transport, fatty acid beta-
oxidation using acyl-CoA dehydrogenase, translation,
tricarboxylic acid (TCA) cycle (also termed citric acid
cycle) and mitochondrial translation (Fig. 3c). By con-
trast, downregulated proteins were mainly involved in
biological processes of pinocytosis, double-strand break
repair via break-induced replication (Fig. 4c). These find-
ings indicated that the differentially expressed proteins
were mainly involved in mitochondria and energy metab-
olism during osteoclastogenesis in the low serum culture
system.
Functional interaction network analysis of the
differentially expressed proteins
To investigate functional interaction network of the differ-
entially expressed proteins, the ClueGO Cytoscape plugin
was used. Of the 549 differentially expressed proteins, 548
proteins were successfully mapped to the REACTOME
database, and one protein (Accession Number: B9EJ86)
failed to map to the database. Our results revealed that
the differentially expressed proteins mainly participated in
mitochondrial fatty acid beta-oxidation, mitochondrial
translation, fatty acyl-CoA biosynthesis, the TCA cycle
as well as respiratory election transport, among others
(Fig. 5). These findings again indicated that the differ-
entially expressed proteins were implicated in mito-
chondrial activities and energy metabolism activities.
Molecular pathways analysis of the differentially
expressed proteins
To further investigate the interaction networks of the
differentially expressed proteins, we used WebGestalt
online toolkit to perform pathway enrichment analysis
based on the Wikipathways database, and used the Wiki-
pathways Cytoscape plugin to visualize the changes in the
molecular pathways. Consistent with functional inter-
action network analysis, molecular pathway enrichment
analysis demonstrated that electron transport chain path-
way, TCA cycle pathway, mitochondrial LC-fatty acid
beta-oxidation pathway and fatty acid biosynthesis path-
way were significantly altered (Additional file 2: Table S2).
In the electron transport chain, expression of 45 matched
proteins were upregulated; these proteins were involved
in mitochondrial complex I (NADH-Ubiquinone oxido-
reductase complex), the ubiquinol-cytochrome C re-
ductase complex and ATP synthase F1 complex (Fig. 6).
In the TCA cycle pathway, 19 identified proteins were
Fig. 5 Functional interaction network analysis of the differentially expressed proteins mapped to the REACTOME database using ClueGO
cytoscape plugin
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upregulated (Fig. 7). In the mitochondrial LC-fatty
acid beta-oxidation pathway, our results showed that
seven proteins, including ACADS, ACADVL, HADHA,
HADH, ACADM, CPT2 and ACSL3, were upregulated,
especially those involved in saturated fatty acid (Fig. 8).
Similarly, in the fatty acid biosynthesis pathway, all eight
identified proteins were upregulated, especially in mito-
chondrion (Fig. 9). Together, our results suggested that
mitochondrial activity and energy metabolism were re-
markably upregulated in the differentiation of RAW 264.7
cells into osteoclasts in the low serum culture system.
Discussion
In the present study, we investigated the proteomic
changes during osteoclastogenesis in medium supple-
mented with 1 % FBS. Consistent with our previous study
[13], our results confirmed that large TRAP-positive
multinucleated osteoclasts with bone resorbing capacity
were successfully obtained by this culturing procedure,
validated by upregulation of 15 characteristic marker pro-
teins, including TRAP, CTSK, MMP9, V-ATPase and
ITGAV, three of which were also confirmed by western
blot analysis. Previous study found 867 proteins (492
down-regulated proteins and 375 upregulated proteins)
altered between osteoclasts and RAW264.7 cells [14],
while our study found 549 proteins (541 upregulated pro-
teins and 8 downregulated proteins) expressed differen-
tially during osteoclastogenesis in the low serum culture
system, and almost all the differentially expressed proteins
were significantly upregulated. Integrated bioinformatics
analysis indicated that these differentially expressed pro-
teins were mainly involved in mitochondrial activities and
energy metabolism, including the electron transport chain
pathway, TCA cycle pathway, mitochondrial LC-fatty
acid beta-oxidation pathway and fatty acid biosynthesis
pathway.
The electron transport chain is a complex biological
process that transfers electrons from electron donors to
electron acceptors [18]. The electron transport chain
pathway is responsible for the synthesis of ATP, the most
commonly consumed chemical energy utilized in a di-
versity array of cellular biological activities, including
osteoclast formation [14, 19-21]. In eukaryotic cells,
ATP is mainly generated in mitochondria. An et al.
found that mitochondrial changes were critical in osteo-
clastogenesis in the conventional 10 % serum culture
system [14]. Moreover, our previous study indicated that
the expression of the electron transported chain in
RAW264.7 cultured in low serum system was downreg-
ulated [13]. In this study, our results showed that the
differentially expressed proteins were mainly located in
mitochondria, suggesting changes in electron trans-
ported chain in osteoclasts formed in the low serum cul-
ture system. Similar to our results, Morten et al. found
increased mitochondrial electron transport chain activity
in the differentiation of human CD14 positive monocytes
differentiating into osteoclasts under hypoxia conditions
[22]. Moreover, Jin et al. reported that a mitochondrial
complex 1 subunit Ndufs4 deletion caused systemic
inflammation and osteopetrosis, and suggested that
Fig. 6 Visualization of all differentially expressed proteins mapped to the electron transport chain pathway in the development of RAW 264.7
cells into osteoclasts in low serum culture system. Gray boxes indicate proteins not mapped, green boxes indicate downregulated proteins, red
boxes indicate upregulated proteins. Color intensity is adjusted to indicate the ratio value
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mitochondrial complex I promoted osteoclast differenti-
ation, while inhibited macrophage activation [23]. In
agreement with Jin et al., we found that mitochondrial
complex I was activated in osteoclasts formed in low
serum culture system. Taken together, these findings
suggested that osteoclasts formation is an energy con-
suming procedure, regardless of the culture environ-
mental condition.
ATP synthesis depends on the products of citric acid
cycle (also termed TCA cycle) and fatty acid oxidation
[24, 25]. Dodds et al. found that osteoclast formation
was related to enhanced TCA cycle and increased fatty
acid oxidation [26]. Our study supports this conclusion,
as bioinformatics analysis showed differentially expressed
proteins enriched in TCA cycle pathway and the mito-
chondrial LC-fatty acid beta-oxidation pathway. The TCA
cycle is a biological process that oxidizes acetyl-CoA for
ATP production [27]. Our results showed high activation
of TCA cycle pathway in osteoclasts generated in medium
supplemented with 1 % FBS. Fatty acids are carboxylic
acids, which have a long aliphatic tail [28]. Fatty acid
oxidation mostly occurs in the mitochondria and is an
energy productive biological procedure. Adamek et al.
suggested that fatty acid oxidation played an important
role in the energy metabolism of bone cells, including
osteoblast and fibroblasts [29]. However, the role of fatty
acid oxidation in osteoclasts has not been reported. In
this study, our results demonstrated that differentially
expressed proteins from the fatty acid oxidation path-
way upregulated significantly, indicating a role of fatty
acid oxidation in the development of RAW 264.7 cells
into osteoclasts in the low serum culture system. Again,
these findings imply that formation and bone resorp-
tion of osteoclast require high ATP production.
Since both the TCA cycle and fatty acid oxidation are
associated with fatty acid biosynthesis, we also analyzed
alternations of fatty acid biosynthesis pathway in osteo-
clastogenesis in the low serum culture system. A previous
study by Cornish et al. indicated that saturated fatty
acid suppressed osteoclast formation in conventional
Fig. 7 Visualization of all differentially expressed proteins mapped to the TCA cycle pathway in the development of RAW 264.7 cells into
osteoclasts in low serum culture system. Gray boxes indicate proteins not mapped, green boxes indicate downregulated proteins, red boxes
indicate upregulated proteins. Color intensity is adjusted to indicate the ratio value
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culture system [30]. Moreover, Kim et al. suggested
that a medium-chain fatty acid suppressed osteoclas-
togenesis by inhibiting RANKL-induced IκBα phos-
phorylation, p65 nuclear translocation, and NF-κB
transcriptional activity. They also found that NFATc1
was inhibited by medium-chain fatty acid in osteo-
clastogenesis in conventional culture system [31]. In
contrast, we found that fatty acid biosynthesis, mainly
of saturated fatty acid, was upregulated in mitochon-
drion of osteoclasts formed in the low serum culture
system. This difference may be because the osteoclasts
were cultured in medium supplemented with low serum
in our study. Therefore, our study suggested a different
process of fatty acid biosynthesis in osteoclasts formed in
low serum culture system from those in conventional cul-
ture system.
Additionally, cells are always pre-treated with serum
free medium for 24 h or less before the start of the
experiments to enhance the sensitivity of cells to drugs.
We hypothesize that there might be differences between
the proteomes of osteoclasts cultured in low serum
system and a serum-free system for only 24 h. However,
to the best of our knowledge, the effect of serum-free
treatment on the osteoclast proteome has not been re-
ported. Therefore, the comparison of effects of continuous
low serum and transient serum free on osteoclasts cannot
be done. Larsson et al. previously investigated the effects
of short exposure to serum-free medium on 3 T3 cells
proliferation cycle, and suggested that 3T3 cells are very
sensitive to serum depletion during the first part of G1;
only a short exposure to serum-free medium is sufficient
for the cells to leave the cell cycle [32]. However, the ef-
fects of serum-free pretreatment on osteoclast differenti-
ation has not been reported.
Conclusion
In conclusion, our study confirmed that osteoclasts
could be obtained in low serum culture system (1 %
FBS), and demonstrated that osteoclast formation is an
ATP consuming process, no matter if cells are cultured
in a low serum culture system or a conventional culture
system. Like osteoclast formation in the conventional
culture system, the proteomic changes in osteoclasto-
genesis in the low serum culture system mainly involve
mitochondrial activity and energy metabolism. Notably,
our results showed that the fatty acid biosynthesis path-
way was upregulated in osteoclasts cultured in low serum
condition, the molecular mechanisms of which need fur-
ther investigation.
Methods
RAW264.7 cell cultivation and osteoclastogenesis
RAW 264.7 cells (obtained from the Chinese Academy
of Medical Sciences (Beijing, China)) were cultured at a
Fig. 8 Visualization of all differentially expressed proteins mapped to the mitochondrial LC-fatty acid beta-oxidation pathway in the development
of RAW 264.7 cells into osteoclasts in low serum culture system. Gray boxes indicate proteins not mapped, green boxes indicate downregulated
proteins, red boxes indicate upregulated proteins. Color intensity is adjusted to indicate the ratio value
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density of 1.5 × 105 cells/ml in 6 well plates. The cells
were divided into two groups. The cells were cultured
with or without 30 ng/ml RANKL (462-TEC-010, R&D
Systems) in α-MEM (11095–080, Life Technologies)
supplemented with 1 % (v/v) FBS (26140079, Life Tech-
nologies) at 37 °C in a 5 % CO2 incubator. The medium
was refreshed every other day. Both sets of experiments
were run in triplicated independently. On Day 5, RAW
264.7 cells and osteoclasts were harvested and pooled.
Subsequently, the pooled cells were used for proteomic
analysis.
TRAP staining and bone resorption assay
TRAP staining and bone resorption assays were per-
formed to confirm the formation of mature osteoclasts
as described previously [33]. Mature osteoclasts were
defined as TRAP-positive cells containing three or more
nuclei. TRAP staining was conducted using the Acid
Phosphatase Leukocyte kit (387–1, Sigma Aldrich) ac-
cording to the manufacturer’s protocol. Briefly, cells
were rinsed three times with cold PBS. Then, cells were
fixed with Fixative Solution (Citrate Solution, acetone
and 37 % formaldehyde) and rinsed thoroughly. Cells
were incubated in staining solution for 1 h in a 37 °C
water bath protected from light.
The Osteo Assay Surface Plate (3987, Corning) was used
to evaluate the bone resorbing capacity of osteoclasts. On
Day 5, following the aspiration of the medium, 100 μl of
10 % bleach solution was added to each well and incu-
bated for 5 min. Toluidine blue staining was conducted
to enhance the contrast for bone resorbing pit image
analysis.
Sample preparation and TMT labeling
Sample preparation and labeling were performed as
described by Xiong et al. [34]. In brief, cells were washed
Fig. 9 Visualization of all differentially expressed proteins mapped to the fatty acid biosynthesis pathway in the development of RAW 264.7 cells
into osteoclasts in low serum culture system. Gray boxes indicate proteins not mapped, green boxes indicate downregulated proteins, red boxes
indicate upregulated proteins. Color intensity is adjusted to indicate the ratio value
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three times with cold PBS, and then lysed with lysis
buffer (8 M urea in PBS, 1 × cocktail, 1 mM PMSF). Cell
lysates were centrifuged at 16,000 × g for 10 min at 4 °C,
the supernatants were collected, and protein concentra-
tions were measured with a Nanodrop2000. Following
incubation in 10 mM dithiothreitol (17131801, GE
Healthcare) at 50 °C for 1 h, 100 μg of protein was incu-
bated with 25 mM indole acetic acid (RPN6302, GE
Healthcare) in the dark for 2 h. Then, trypsin/Lys-C Mix
(V5072, Promega) was used to digest proteins overnight
at 37 °C at a protein/protease ratio of 25:1, and the
reaction was quenched by heating at 60 °C. Proteins
digests were desalted, dried and solved in 200 mM
triethylammonium bicarbonate buffer. TMT Isobaric
Label Reagent Set (90061, Thermo Scientific) was used
to label proteins according to the manufacturer’s in-
structions. Proteins extracted from osteoclasts and RAW
264.7 cells were labeled with 0.8 mg TMT6-128 or
TMT6-127, respectively. Equal amounts of the labeled
protein digests from both groups were pooled, dried and
solved in 0.1 % trifluoroacetic acid. Then the protein
digests were finally solved in 100 μl of 0.1 % trifluoroa-
cetic acid for mass spectrometry (MS) analysis.
High-performance liquid chromatography (HPLC)
Fractionation of pooled protein digests was performed
as described by van Ulsen et al. [35]. Briefly, the pooled
TMT labeled protein digests were dissolved in 100 μl
0.1 % formic acid for HPLC analysis (UltiMate 3000
UHPLC, Thermo Scientific) using an Xbridge BEH300
C18 column (4.6 × 250 mm2, 5 μm, 300 Å, Waters). Fifty
fractions were collected at 1.5 min intervals. The frac-
tions were dried in a vacuum concentrator. Then, 20 μl
0.1 % FA was used to dissolve the fractions for LC-MS/
MS analysis.
LC-MS/MS analysis
LC-MS/MS was conducted using a Q Exactive mass
spectrometer. The protein digests were separated using
a 120 min gradient elution at a flow rate of 0.3 μl/min
using the UltiMate 3000 RSLCano System (Thermo
Scientific). A directly interfaced Q Exactive Hybrid
Quadrupole-Orbitrap Mass Spectrometer (Thermo Sci-
entific) was used to analyze the protein digests. We use
a home-made fused silica capillary column (75 μm×
150 mm, Upchurch, Oak Harbor, WA, USA) packed
with C18 resin (300 Å, 5 μm, Varian Lexington, MA,
USA) as the analytical column. Xcalibur 2.1.2 software
was used with the Q Exactive mass spectrometer in
data-dependent acquisition mode. Ten data-dependent
MS/MS scans at 27 % normalized collision energy were
performed. Thereafter, a single full-scan mass spectrum
in Orbitrap (400–1,800 m/z, 60, 000 resolution) was
conducted.
Western blot analysis
To validate the LC-MS/MS data and to confirm the for-
mation of osteoclasts, western blot analysis of three
characteristic osteoclast biomarkers and two other altered
proteins was performed according to standard procedure
with minor modifications. Equal amounts of total proteins
of RAW264.7 cells and osteoclasts cultured in low serum
(20 μg) were separated by SDS-PAGE on 12 % gel and
transferred to nitrocellulose membranes. Membranes were
blocked at room temperature for 1 h in Tris Buffer Saline
with Tween 20 (TBST) with 5 % nonfat milk. Then, mem-
branes were incubated with anti-TRAP (sc-28204), anti-
CTSK (ab19027), anti-histone H4 (ab10158), anti-MMP-9
(ab137867), anti-ANXA1 (sc-12740) and anti-beta tubulin
(internal control) antibody (KM9003) at 4 °C overnight.
After washing in TBST for 15 min, membranes were
incubated with goat anti-rabbit horseradish peroxidase
(HRP)-conjugated IgG for 1 h at room temperature.
Membranes were then washed three times in TBST and
bands were visualized with ECL detection kits (GE
Healthcare, RPN2209) according to the manufacturer’s
instructions.
Data analysis
Thermo Scientific Proteome Discoverer software suite
1.4 with the SEQUEST search engine and the mouse
FASTA database from UniProt (released on October
16th, 2015) was used to analyze LC-MS/MS data. In the
SEQUEST search engine, full trypsin specificity was
selected, two missed cleavages were allowed, carba-
midomethylation (C) and TMT 6-plex (K and peptide
N-terminal) were set as the static modification, oxida-
tion (M) was set as the dynamic modification, precur-
sor ion mass tolerances were set at 20 ppm for all
MS data acquired using an Orbitrap mass analyzer,
and the fragment ion mass tolerance was set as 20
mmu for all MS/MS spectra acquired. Two or more
unique peptides per protein had to be identified to
list the protein as a hit. Proteins that scored 10 or
more were selected for subsequent bioinformatics analysis.
The ratio values of proteins labeled with TMT6-128 and
TMT6-127 were adjusted using the beta tubulin ratio
value as internal control. The thresholds for downregula-
tion and upregulation were set at 0.5 and 2.0 respectively.
FunRich software (version 2.1.2) (www.funrich.org) was
used to classify the proteins using UniProt Database (re-
leased on July 21st, 2015). The ClueGO cytoscape plugin
(version 2.1.7) was used to analyze the functional inter-
action networks of the differentially expressed proteins.
The REACTOME ontology database (released on May 5th,
2015) was used. Two-sided hypergeometric tests with
Benjamini-Hochberg correction method were performed to
minimize the false discovery rate. Pathways with P
value of 0.01 or less were considered as significance.
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The WebGestalt online toolkit (http://bioinfo.vanderbilt.
edu/webgestalt/) was used to run pathway enrichment
analysis and the significance level was set at 0.0001. Cytos-
cape software (version 3.1.1) with Wikipathways plugin
was used to visualize the protein-protein interactions
matching the Wikipathways database. The mass spec-
trometry proteomics data have been deposited to the
ProteomeXchange Consortium via the PRIDE partner
repository with the data identifier PXD001935 [36].
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